Recent DNLI News
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 03/01/2024 09:51:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2024 01:07:37 PM
- Denali Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights • GlobeNewswire Inc. • 02/27/2024 01:05:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2024 01:03:38 PM
- Denali Therapeutics Announces $500 million Private Placement Equity Financing • GlobeNewswire Inc. • 02/27/2024 01:00:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 01:02:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 02:15:20 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 02:14:42 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 02:14:01 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/14/2024 09:59:21 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/14/2024 09:43:55 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/14/2024 01:19:50 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/14/2024 01:18:42 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/14/2024 01:17:46 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/12/2024 09:48:27 PM
- Denali Therapeutics Announces New Data and Expansion of Its Blood-Brain Barrier (BBB)-Crossing Enzyme Replacement Therapy Programs at WORLDSymposium™ • GlobeNewswire Inc. • 02/07/2024 01:00:00 PM
- Denali Therapeutics Announces Presentations on Its Investigational Blood-Brain Barrier (BBB)-Crossing Enzyme Replacement Therapies at the Upcoming 2024 WORLDSymposium™ • GlobeNewswire Inc. • 02/01/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/13/2024 01:18:53 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/11/2024 10:28:16 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/10/2024 09:09:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/10/2024 12:35:34 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/10/2024 12:34:07 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/10/2024 12:33:21 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/10/2024 12:20:52 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 01:06:38 PM
VPR Brands LP Reports Record Annual Financial Performance for Fiscal Year 2023 • VPRB • Apr 19, 2024 11:24 AM
Coinllectibles' Subsidiary, Grand Town Development Limited, Acquires Rare Song Dynasty Ceramics Worth Over USD28million • COSG • Apr 18, 2024 8:03 AM
ILUS Provides Form 10-K Filing Update • ILUS • Apr 17, 2024 9:54 AM
Glucotrack Announces Expansion of Its Continuous Glucose Monitoring Technology to Epidural Glucose Monitoring • GCTK • Apr 17, 2024 8:00 AM
Maybacks Global Entertainment To Fire Up 24 New Stations in Louisiana • AHRO • Apr 16, 2024 1:30 PM
Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix • BLOZF • Apr 16, 2024 8:52 AM